# Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department

> **NCT01534806** · PHASE4 · WITHDRAWN · sponsor: **Akron Children's Hospital**

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01534806
- **Lead sponsor:** Akron Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug is backordered;
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01534806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01534806, "Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01534806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*